Suchergebnisse - "Goedeker, Natalie L"

PubPharm (6)

1

Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy

enthalten in: Journal of neuromuscular diseases | 2024

von Zaidman, C. | Goedeker, N. | Aqul, A. | +11

2

Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy : 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR)

enthalten in: Annals of neurology | 2023

von Zaidman, C. | Proud, C. | McDonald, C. | +15

3

Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy

enthalten in: Therapeutic advances in neurological disorders | 2023

von Goedeker, N. | Dharia, S. | Griffin, D. | +7

4

Laboratory monitoring of nusinersen safety

enthalten in: Muscle & nerve | 2021

von Goedeker, N. | Gibbons, J. | Varadhachary, A. | +2

5

Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy : A Case Series

enthalten in: The Journal of pediatrics | 2021

von Chand, D. | Zaidman, C. | Arya, K. | +7

6

Laboratory monitoring of nusinersen safety

enthalten in: Muscle & Nerve | 2021

von Goedeker, N. | Gibbons, J. | Varadhachary, A. | +2

1
[1]